The insidious growth of pancreatic cancer is a major factor contributing to its lethality. Only 10-15% of pancreatic cancers are resectable by the time they are detected. Early detection of pancreatic cancer through routine screening is clearly an unmet clinical need. Here we have applied neural network analysis to 1H magnetic resonance spectra of human plasma samples to differentiate between healthy subjects (control), subjects with benign lesions, and subjects with pancreatic ductal adenocarcinoma (PDAC). Our data support developing a neural-network approach to identify PDAC from 1H MRS of plasma samples.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords